✦ LIBER ✦

Shared determinants of receptor binding for subtype selective, and dual endothelin-angiotensin antagonists on the AT1 angiotensin II receptor

✍ Scribed by David Dascal; Vaneet Nirula; Kimberly Lawus; Sung-Eun Yoo; Thomas F Walsh; Kathryn Sandberg

Book ID: 117108736
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 222 KB
Volume: 423
Category: Article
ISSN: 0014-5793
DOI: 10.1016/s0014-5793(98)00040-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EXP597, a nonpeptide angiotensin II rece

EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes

✍ Pancras C. Wong; John V. Duncia; Joseph B. Santella III; Ronald D. Smith; Ruth R 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 387 KB

The design, binding affinity prediction

The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists

✍ Stephen E. de Laszlo; Tomasz W. Glinka; William J. Greenlee; Richard Ball; Rober 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Development of angiotensin II antagonist

Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.

✍ Tomasz W. Glinka; Stephen E. de Laszlo; Peter K.S. Siegl; Raymond S. Chang; Sala 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 464 KB

Angiotensin II AT1 receptor antagonists

Angiotensin II AT1 receptor antagonists inhibit the angiotensin-CRF-AVP axis and are potentially useful for the treatment of stress-related and mood disorders

✍ Juan M. Saavedra; Jaroslav Pavel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Effects of cimetidine on pharmacokinetic

Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist

✍ M. R. Goldberg; M. W. Lo; T. E. Bradstreet; M. A. Ritter; P. Högland 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 512 KB

This was a 2-period randomized, crossover study in 8 healthy males to determine the effects of cimetidine (400 mg q.i.d. for 6 days) on the pharmacokinetics and pharmacodynamic effects of the angiotensin II receptor antagonist, losartan (100 mg). Cimetidine increased the AUC for losartan 18% without

Action of AT1 subtype angiotensin II rec

Action of AT1 subtype angiotensin II receptors of the medial preoptic area on gonadotropins and prolactin release

✍ R.C.M Dornelles; C.R Franci 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 537 KB